OakChart

CollPlant Biotechnologies Ltd

CLGNHealthcare·Biotechnology·Israel·Nano·NASD·Nov 11 • 3:59 PM ET

3.96+0.06 (1.41%)
2026-11-11 22:36 CET
Market cap
7.38 USD m
Revenue, TTM
0.32 USD m
Net income, TTM
-12.51 USD m
Free cash flow, TTM
-11.98 USD m
EPS diluted, TTM
-9.38
P/E
-
Compare

Price

CLGN against its 20, 50 and 200-day averages
2050200earnings
5.0010.0015.009.1M18.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CLGNclose 3.9620-day 3.9250-day 3.82200-day 4.613.9652w low

82.4% under the 52-week high of 22.50 on 28 Nov 2025. 52-week low 2.64 on 28 Aug 2026. Last 15 sessions, 37.8% high to low

Volume 0.07× normal · the line is the 50-bar volume average

Profile

CLGN
52-week range, 7% of the way up
2.6422.50

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Employees39
IPOMay 21, 2015
Beta0.57
ATR, 14d0.41
Rel volume0.07
Short float2.28%
Insider own17.54%
Inst own9.58%

Snapshot

6 groups

Valuation

Index-
Market Cap7.48M
Enterprise Value7.19M
Income-12.51M
Sales0.32M
Book/sh2.04
Cash/sh1.56
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees39
IPOMay 21, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S23.39
P/B1.94
P/C2.54
P/FCF-
EV/EBITDA-
EV/Sales22.48
Quick Ratio1.35
Current Ratio1.57
Debt/Eq0.90
LT Debt/Eq0.60
Option/ShortNo / Yes

Earnings

EPS (ttm)-9.38
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y15.02% -2.35%
Sales past 3/5Y99.41% -17.32%
EPS Y/Y TTM16.63%
Sales Y/Y TTM-86.76%
EPS Q/Q33.15%
Sales Q/Q-39.66%
EarningsSep 30 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own17.54%
Insider Trans0.00%
Inst Own9.58%
Inst Trans-1.02%
ROA-101.59%
ROE-161.98%
ROIC-265.61%
Gross Margin-587.74%
Oper. Margin-3900.94%
Profit Margin-3934.91%
SMA201.01%
SMA503.80%
SMA200-14.13%
Trades-

Technical

Shs Outstand1.89M
Shs Float1.56M
Short Float2.28%
Short Ratio0.10
Short Interest0.04M
52W High22.50 -82.40%
52W Low2.64 50.17%
Volatility9.70% 9.23%
ATR (14)0.41
RSI (14)50.81
Beta0.57
Rel Volume0.07
Avg Volume364.42K
Volume23,866

Performance

Perf Week-6.38%
Perf Month1.28%
Perf Quarter24.29%
Perf Half Y-5.42%
Perf YTD-71.71%
Perf Year-79.16%
Perf 3Y-92.95%
Perf 5Y-98.14%
Perf 10Y-97.79%
Recom3.00
Target Price120.00
Prev Close3.90
Price3.96
Change %1.41%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Feb 17, 2023InitiatedAAlliance Global PartnersBuy$22.75+474.5%

Peers

Mkt cap
TickerCompanyMkt cap
PLXProtalix BioTherapeutics Inc252.18M
DYAIDyadic International Inc, DE15.54M
MLECMoolec Science SA0.62M
HUMAHumacyte Inc164.37M
FBLGFibroBiologics Inc6.63M
MDXGMimedx Group Inc484.47M
BSEMBioStem Technologies Inc27.45M
VCELVericel Corp3.03B
BBLGBone Biologics Corp1.19M
EVGNEvogene Ltd7.14M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Loewenbaum Lilian S.10% OwnerOct 27 '26Proposed Sale3.7915,55058,934Oct 27 11:25 AM

News

latest 14 of 100
  • LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26 (GlobeNewswire)
  • LightSolver and Why AI May Outrun the GPU (NASDAQ: CLGN) (FinanceWire) +8.99%
  • COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT (PR Newswire) -11.59%
  • LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations (PR Newswire)
  • COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire) -5.56%
  • LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads (PR Newswire)
  • CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -10.47%
  • CollPlant to Host LightSolver Investor Webinar on September 17, 2026 (PR Newswire)
  • COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION (PR Newswire)
  • COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR (PR Newswire)
  • COLLPLANT ANNOUNCES REVERSE SHARE SPLIT (PR Newswire) -7.86%
  • COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS (PR Newswire) +8.35%
  • COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT (PR Newswire)
  • COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-09-30-1.890--1.8900.11--
2026Q12026-05-29-2.300--2.2530.07--
2025Q42026-03-26-2.568-2.977-2.5050.062.081
2025Q32025-11-26-2.7001.554-2.7380.084.842
2025Q22025-08-20-2.800-1.000-2.8270.182.541
2025Q12025-05-281.300-0.400-1.2682.062.651
2024Q42025-03-26-3.300-1.300-3.3860.170.101
2024Q32024-11-27-3.800-2.850-3.7770.000.422
2024Q22024-08-20-3.700-2.700-3.6750.250.402
2024Q12024-05-29-3.700-3.500-3.6630.100.641
2023Q42024-04-04-4.0002.400-4.0940.318.561
2023Q32023-11-29-3.800-1.300-3.8250.043.503
2023Q22023-08-244.900-0.8334.89310.183.593
2023Q12023-05-24-3.300-2.900-3.2960.430.243
2022Q42023-03-29-3.800-3.150-3.9340.410.102
2022Q32022-12-01-4.000-3.100-3.9500.110.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-22.400-5.150-22.3892.322.76
2020FY-8.400-10.650-8.3846.886.89
2021FY0.2003.2000.19815.6415.33
2022FY-15.300-13.400-15.3400.300.32
2023FY-6.2001.100-6.16310.9619.22
2024FY-14.500-10.800-14.5000.520.45
2025FY-9.400-9.800-9.4152.374.39
2026FY--5.851--2.00
2027FY--1.803--2.50
2028FY--1.677--3.00
2029FY--1.500--3.50
2030FY--1.400--4.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-04-211000.520.520.52
2026Q3S2026-03-261010.520.520.52
2026Q3S2026-02-051010.520.520.52
2026Q3S2025-11-281004.684.684.68
2026Q3S2025-11-262002.941.204.68
2026Q3S2025-11-112002.941.204.68
2026Q3S2025-11-102002.941.204.68
2026Q3S2025-11-092002.941.204.68
2026Q3S2025-11-082002.941.204.68
2026Q3S2025-11-072002.941.204.68
2026Q3S2025-11-062002.941.204.68
2026Q3S2025-11-052002.941.204.68
2026Q3S2025-11-042002.941.204.68
2026Q3S2025-11-032002.941.204.68

Estimate history

EPS, annual-0.445-0.285-22.389-8.3840.198-15.34-6.163-14.5-9.415-9.385
Period201720182019202020212022202320242025TTM
EPS, quarterly-3.675-3.777-3.386-1.268-2.827-2.738-2.505-2.253-1.89
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.4645.0142.3186.13715.6410.29910.9590.5152.3710.32
Period201720182019202020212022202320242025TTM
Sales, quarterly0.2490.0040.1642.0550.1790.0770.060.0730.108
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual16.5919.0740.5670.6961.0771.1191.1451.1451.281.444
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.1451.1451.1451.1451.2721.2781.281.4421.444
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.322.370.5210.960.3015.646.142.325.01
Cost of Goods Sold Incl. D&A2.191.752.663.091.482.013.462.271.90
Gross Profit-1.870.62-2.157.87-1.1813.642.680.053.11
Selling, General and Administrative Excl. Other10.5412.1115.1015.3815.9213.578.287.717.68
Research and Development6.918.1910.5210.4810.267.633.664.093.98
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-12.40-11.48-17.25-7.51-17.100.07-5.60-7.66-4.57
Interest Expense-0.020.020.010.030.040.030.070.03
Unusual Expense0.000.000.000.000.00-0.03-0.043.232.15
Net Income Before Taxes-12.51-11.49-16.61-7.02-16.930.24-5.77-11.16-6.25
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-12.51-11.49-16.61-7.02-16.930.24-5.77-11.16-6.25
Net Income From Continuing Operations-12.51-11.49-16.61-7.02-16.930.24-5.77-11.16-6.25
Net Income-12.51-11.49-16.61-7.02-16.930.24-5.77-11.16-6.25
EPS (Recurring)-8.67-9.41-14.50-6.16-15.340.18-8.42-17.85-0.22
EPS (Basic, Before Extraordinaries)-9.38-9.41-14.50-6.16-15.340.24-8.38-22.39-0.28
EPS (Diluted)-9.38-9.41-14.50-6.16-15.340.20-8.38-22.39-0.28
EBITDA-11.56-10.57-16.21-6.41-16.020.84-4.94-7.12-4.23
Non-Operating Income (Expense)0.040.010.660.500.210.18-0.18-0.200.50
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-1.001.721.942.171.621.610.871.09
Price To Earnings Ratio-----62.37---
Price To Sales Ratio15.837.2180.076.64308.1212.5212.0912.26183.64
Gross Margin-587.7426.32-417.0971.78-393.6587.1843.652.2462.07
Operating Margin-3,900.94-484.31-3,349.71-68.55-5,718.060.42-91.23-330.41-91.18
Net Margin-3,934.91-484.56-3,225.05-64.05-5,660.541.52-94.09-481.62-124.63
Shares Outstanding1.441.281.151.151.121.080.700.5719.07
Market Capitalization7.387.3841.2473.1892.57176.2375.00323.24801.09

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.110.070.060.080.182.060.160.00
Cost of Goods Sold Incl. D&A0.760.530.410.490.420.430.510.53
Gross Profit-0.65-0.45-0.35-0.41-0.241.62-0.35-0.52
Selling, General and Administrative Excl. Other1.982.662.803.092.943.273.624.02
Research and Development1.171.681.982.092.012.112.542.87
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.63-3.12-3.15-3.51-3.18-1.65-3.97-4.54
Interest Expense0.09-0.06-0.17---
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-2.73-3.10-3.21-3.48-3.35-1.45-3.88-4.33
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-2.73-3.10-3.21-3.48-3.35-1.45-3.88-4.33
Net Income From Continuing Operations-2.73-3.10-3.21-3.48-3.35-1.45-3.88-4.33
Net Income-2.73-3.10-3.21-3.48-3.35-1.45-3.88-4.33
EPS (Recurring)-1.89-2.25-2.50-2.74-2.83-1.27-3.39-3.78
EPS (Basic, Before Extraordinaries)-1.89-2.25-2.50-2.74-2.83-1.27-3.39-3.78
EPS (Diluted)-1.89-2.25-2.50-2.74-2.83-1.27-3.39-3.78
EBITDA-2.44-2.90-2.93-3.28-2.95-1.40-3.73-4.29
Non-Operating Income (Expense)0.000.020.000.020.000.200.100.22
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.170.18-0.280.360.380.420.52
Price To Sales Ratio15.8318.947.5613.836.7011.9580.0787.49
Gross Margin-604.63-620.55-580.00-538.96-131.8478.98-213.41-13,075.00
Operating Margin-2,437.96-4,267.12-5,250.00-4,554.55-1,775.42-80.19-2,423.17-113,550.00
Net Margin-2,524.07-4,242.47-5,345.00-4,523.38-1,869.83-70.66-2,364.63-108,150.00
Shares Outstanding1.441.441.281.281.271.151.151.15
Market Capitalization7.387.7317.9234.3717.2929.5541.2456.87

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments5.9512.1626.9129.6843.313.353.805.515.13
Short Term Receivables0.000.150.000.010.270.830.080.520.63
Inventories0.570.440.711.431.081.260.890.810.20
Other Current Assets0.220.430.390.540.420.240.270.330.49
Total Current Assets6.7513.1828.0231.6645.095.685.047.176.46
Net Property, Plant & Equipment3.895.285.865.685.684.905.541.411.03
Total Investments and Advances0.080.120.060.190.210.180.170.150.14
Long-Term Note Receivable------0.000.020.03
Intangible Assets0.070.130.190.240.240.080.000.000.42
Other Assets0.000.000.000.000.000.000.000.000.00
Total Assets10.7918.7134.1337.7751.2210.8410.758.758.08
Short Term Debt Incl. Current Port. of LT Debt0.810.810.620.530.520.440.480.020.00
Accounts Payable0.610.870.981.131.030.800.830.620.84
Other Current Liabilities1.251.291.651.441.462.152.151.590.57
Total Current Liabilities2.672.973.253.103.013.393.462.231.42
Long Term Debt2.032.272.542.383.092.953.140.023.64
Provision for Risks Charges0.000.000.000.000.000.000.000.00-
Other Liabilities0.000.000.000.000.000.030.071.080.06
Total Liabilities4.705.255.795.496.106.366.663.335.12
Non-Equity Reserves0.000.000.000.000.000.000.000.000.35
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6.0813.4628.3432.2845.124.484.095.422.62
Total Shareholders Equity6.0813.4628.3432.2845.124.484.095.422.62
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity6.0813.4628.3432.2845.124.484.095.422.62
Total Liabilities & Stockholders Equity10.7918.7134.1337.7751.2210.8410.758.758.08
Book Value Per Share4.7511.7624.7528.8641.896.437.210.280.16
Tangible Book Value Per Share4.6911.6424.5828.6441.666.317.210.280.13
Full-Time Employees395775736652464239
Price to Book Ratio1.923.062.262.593.9116.7579.07166.992,053.36
Return on Assets-77.90-62.87-19.53-38.040.76-53.48-112.35-74.26-98.15
Return on Equity-117.56-79.46-23.16-43.730.96-134.83-251.29-155.52-293.39
Return on Invested Capital-141.61-105.52-22.73-48.830.49-77.76-154.48-114.83-92.77
Quick Ratio2.314.298.409.7414.601.301.202.854.42
Current Ratio2.534.448.6210.2014.961.681.463.214.56

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-13.34-11.49-16.61-7.02-16.930.24-5.77-11.16-6.25
Depreciation0.910.911.041.101.080.770.660.540.34
Other Funds (Non Cash)0.640.901.852.312.701.281.794.683.54
Funds from Operations-11.79-9.67-13.72-3.61-13.152.29-3.33-5.95-2.36
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.100.25-0.370.85-0.540.22-1.120.251.15
Cash from Operating Activities-11.89-9.42-14.09-2.76-13.702.50-4.45-5.70-1.22
Capital Expenditures-0.09-0.03-0.48-0.95-1.32-1.59-0.52-1.49-0.83
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.090.000.000.070.000.030.000.030.00
Purchase or Sale of Investments0.000.00-0.06-0.2730.24-30.000.000.000.00
Purchase of Investments0.000.00-0.06-0.27-20.00-30.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.0050.240.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.01-0.03-0.54-1.1628.92-31.56-0.52-1.46-0.83
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.573.100.011.111.8738.764.495.452.78
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.573.100.011.111.8738.764.495.452.78
Proceedsfrom Stock Options0.640.000.000.000.0032.744.405.442.78
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00-0.02-0.020.05
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-0.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.00-0.02-0.07
Other Financing Activities Uses0.000.000.000.000.000.000.00-0.02-0.07
Cash from Financing Activities2.573.100.011.111.8738.764.475.412.75
Exchange Rate Effect-0.010.03-0.14-0.38-0.610.140.060.06-0.33
Net Change in Cash-9.33-6.32-14.77-3.1916.499.85-0.45-1.690.38
Free Cash Flow-11.98-9.45-14.58-3.72-14.971.07-4.89-7.19-2.05
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-----182.46---
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments2.954.635.958.8311.7110.98
Short Term Receivables0.020.010.000.010.000.00
Inventories0.540.680.570.540.550.67
Other Current Assets0.390.230.220.240.360.44
Total Current Assets3.905.546.759.6212.6212.09
Net Property, Plant & Equipment3.173.513.894.254.584.88
Total Investments and Advances0.080.080.080.130.130.12
Intangible Assets0.040.060.070.090.100.12
Other Assets0.000.000.000.000.000.00
Total Assets7.209.1810.7914.0917.4417.21
Short Term Debt Incl. Current Port. of LT Debt0.890.790.810.790.840.73
Accounts Payable0.260.640.610.620.570.77
Other Current Liabilities1.341.011.251.231.331.20
Total Current Liabilities2.492.442.672.632.742.70
Long Term Debt1.771.852.032.152.192.11
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities4.254.304.704.784.934.81
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2.944.896.089.3012.5112.40
Total Shareholders Equity2.944.896.089.3012.5112.40
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2.944.896.089.3012.5112.40
Total Liabilities & Stockholders Equity7.209.1810.7914.0917.4417.21
Book Value Per Share2.043.394.757.289.8310.82
Tangible Book Value Per Share2.013.354.697.219.7510.72
Full-Time Employees--39---
Price to Book Ratio1.921.582.953.691.382.38
Return on Assets-101.59-99.53-77.90-66.57-59.10-58.38
Return on Equity-161.98-151.99-117.56-92.74-78.25-75.27
Return on Invested Capital-57.86-45.94-39.53-30.40-22.78-10.01
Quick Ratio1.351.992.313.454.404.23
Current Ratio1.572.272.533.664.604.48

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-2.88-3.10-3.53-3.84-3.37-1.45
Depreciation0.210.210.240.250.230.24
Other Funds (Non Cash)0.170.17-0.020.320.270.39
Funds from Operations-2.49-2.72-3.31-3.27-2.86-0.82
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.02-0.330.100.110.41-0.34
Cash from Operating Activities-2.47-3.05-3.21-3.16-2.46-1.17
Capital Expenditures-0.07-0.01-0.02-0.00-0.00-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.090.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.01-0.01-0.02-0.00-0.00-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.681.720.050.133.110.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.681.720.050.133.110.00
Proceedsfrom Stock Options0.640.00-3.243.240.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.681.720.050.133.110.00
Exchange Rate Effect-0.000.01-0.01-0.010.040.00
Net Change in Cash-1.78-1.33-3.19-3.040.70-1.17
Free Cash Flow-2.54-3.06-3.23-3.16-2.46-1.18

Revenue breakdown

Revenues From Milestones2025: 2.00M
Revenues From Sales Of Goods2024: 515.00K 2025: 371.00K
Canada2025: 96.00K
Europe And Other2025: 98.00K
Israel2024: 31.00K 2025: 1.00K
United States2024: 484.00K 2025: 2.18M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.28%0.0M1.6M361.01K
2026-10-153.38%0.1M1.6M355.37K
2026-09-302.85%0.0M1.5M350.54K
2026-09-153.53%0.1M1.5M342.99K
2026-08-310.89%0.0M1.5M305.81K
2026-08-140.15%0.0M1.5M5.98K
2026-07-310.11%0.0M1.4M4.98K
2026-07-150.12%0.0M1.4M7.72K
2026-06-300.33%0.0M1.0M9.87K
2026-06-150.20%0.0M1.0M9.37K
2026-05-290.41%0.0M1.0M8.06K
2026-05-150.81%0.0M1.0M9.24K
2026-04-300.78%0.0M1.0M12.73K
2026-04-150.63%0.0M1.0M10.30K
2026-03-310.62%0.0M1.0M7.82K
2026-03-130.68%0.0M1.0M8.11K
2026-02-270.76%0.0M1.0M7.88K
2026-02-131.28%0.0M0.9M6.39K
2026-01-301.25%0.0M0.9M2.72K
2026-01-150.90%0.0M0.9M2.94K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-05SEC
2026-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-04SEC
2026-11-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-03SEC
2026-11-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-02SEC
2026-10-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-29SEC
2026-10-27144Filing for proposed sale of securities under Rule 144.SEC
2026-10-22DNotice of sales of securities on Form D (Regulation D)SEC
2026-10-193Initial statement of beneficial ownership of securities2026-09-03SEC
2026-10-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-15SEC
2026-10-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-09SEC
2026-10-08SCHEDULE 13GSEC
2026-10-08SCHEDULE 13D/ASEC
2026-10-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-06SEC
2026-09-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-22SEC
2026-09-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-18SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-04SEC
2026-09-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-03SEC
2026-09-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-01SEC
2026-08-316-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-31SEC
2026-08-21SCHEDULE 13D/ASEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-18SEC
2026-08-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-06SEC
2026-07-31SCHEDULE 13D/ASEC
2026-07-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-29SEC
2026-07-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-28SEC
2026-07-27SCHEDULE 13D/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
VILLERE ST DENIS J & CO LLC4.13%
PINNACLE ASSOCIATES LTD3.75%
BROWN ADVISORY INC0.73%
RENAISSANCE TECHNOLOGIES LLC0.43%
Pathstone Holdings, LLC0.40%
CITADEL ADVISORS LLC0.37%
Legacy Wealth Managment, LLC/ID0.16%
WATERS PARKERSON & CO., LLC0.09%
XTX Topco Ltd0.09%
FNY Investment Advisers, LLC0.04%

Funds

Fund% owned
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO19.23%
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND17.34%
VANGUARD DEVELOPED MARKETS INDEX FUND15.03%
International Advantage Portfolio14.29%
T. Rowe Price Overseas Stock Fund8.64%
Global Opportunity Portfolio7.99%
Capital Group International Focus Equity ETF7.23%
VANGUARD EMERGING MARKETS STOCK INDEX FUND6.00%
Fidelity International Index Fund4.56%
iShares MSCI EAFE ETF4.28%

OakChart. CLGN. Cached 15 minutes.